• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

American Society of Clinical Oncology Position Statement on Addressing the Affordability of Cancer Drugs.

出版信息

J Oncol Pract. 2018 Mar;14(3):187-192. doi: 10.1200/JOP.2017.027359. Epub 2017 Nov 1.

DOI:10.1200/JOP.2017.027359
PMID:29091534
Abstract
摘要

相似文献

1
American Society of Clinical Oncology Position Statement on Addressing the Affordability of Cancer Drugs.美国临床肿瘤学会关于解决抗癌药物可及性的立场声明。
J Oncol Pract. 2018 Mar;14(3):187-192. doi: 10.1200/JOP.2017.027359. Epub 2017 Nov 1.
2
Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA.生物类似药和仿制药不太可能改变美国癌症药物的成本曲线。
Lancet Oncol. 2017 Jan;18(1):22-23. doi: 10.1016/S1470-2045(16)30653-2.
3
How do biosimilars sustain value, affordability, and access to oncology care?生物类似药如何维持肿瘤治疗的价值、可负担性及可及性？
Expert Rev Pharmacoecon Outcomes Res. 2021 Jun;21(3):327-329. doi: 10.1080/14737167.2020.1813570. Epub 2020 Sep 8.
4
Introduction and commentary: Paving the way for biosimilars in oncology.引言与评论：为肿瘤学中的生物类似药铺平道路
Semin Oncol. 2013 Dec;40 Suppl 1:S1-4. doi: 10.1053/j.seminoncol.2013.09.014. Epub 2013 Oct 4.
5
Economic perspective of cancer treatment in India.印度癌症治疗的经济学视角。
Med Oncol. 2020 Oct 15;37(11):101. doi: 10.1007/s12032-020-01424-3.
6
Affordability of Cancer Drugs in Sub-Saharan Africa: Effects of Pricing on Needless Loss of Life.撒哈拉以南非洲地区癌症药物的可负担性：定价对不必要生命损失的影响。
JAMA Oncol. 2017 Oct 1;3(10):1301-1302. doi: 10.1001/jamaoncol.2017.0479.
7
Emerging Opportunities and Challenges of Biosimilars in Oncology Practice.生物类似药在肿瘤学实践中的新机遇与挑战
J Oncol Pract. 2017 Sep;13(9_suppl):7s-9s. doi: 10.1200/JOP.2017.026831.
8
Biosimilars in Oncology: Reality Could Bite the Copycats, Dog Potential Major Savings.肿瘤学中的生物类似药：现实可能会打击仿制药制造商，有望大幅节省成本。
Manag Care. 2017 Mar;26(3):28-30.
9
The shortage of essential chemotherapy drugs in the United States.美国必需化疗药物的短缺。
N Engl J Med. 2011 Nov 3;365(18):1653-5. doi: 10.1056/NEJMp1109772. Epub 2011 Oct 31.
10
Journey of Generic Imatinib: A Case Study in Oncology Drug Pricing.通用型伊马替尼的历程：肿瘤学药物定价案例研究
J Oncol Pract. 2017 Jun;13(6):352-355. doi: 10.1200/JOP.2016.019737. Epub 2017 Apr 26.

引用本文的文献

1
Eligibility and Accessibility Barriers of Patient Assistance Programs for Oral Oncolytics in Patients With Cancer.癌症患者口服溶瘤药物患者援助项目的资格与可及性障碍
Clin J Oncol Nurs. 2025 Jan 17;29(1):79-85. doi: 10.1188/25.CJON.79-85.
2
Barriers to early diagnosis and treatment of cervical cancer in Addis Ababa, Ethiopia: qualitative study.埃塞俄比亚亚的斯亚贝巴宫颈癌早期诊断和治疗的障碍：定性研究
BMJ Open. 2025 Jan 15;15(1):e087792. doi: 10.1136/bmjopen-2024-087792.
3
Cancer Drug Price and Novelty in Mechanism of Action.癌症药物的价格与作用机制的新颖性。
JAMA Netw Open. 2023 Dec 1;6(12):e2347006. doi: 10.1001/jamanetworkopen.2023.47006.
4
Reducing Chemotherapy Waiting Times in the Ambulatory Setting of a Tertiary Cancer Centre Using a Design Thinking Approach.在三级癌症中心的门诊环境中采用设计思维方法减少化疗等待时间
Cancers (Basel). 2023 Sep 19;15(18):4625. doi: 10.3390/cancers15184625.
5
Association of Household Income at Diagnosis With Financial Toxicity, Health Utility, and Survival in Patients With Head and Neck Cancer.诊断时家庭收入与头颈部癌症患者的财务毒性、健康效用和生存的关联。
JAMA Otolaryngol Head Neck Surg. 2023 Jan 1;149(1):63-70. doi: 10.1001/jamaoto.2022.3755.
6
Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China: An Interrupted Time Series Study.国家医保药品目录谈判政策对中国抗癌药物可及性的影响：一项中断时间序列研究
Front Public Health. 2022 Jul 1;10:921093. doi: 10.3389/fpubh.2022.921093. eCollection 2022.
7
The Cancer Financial Experience (CAFÉ) study: randomized controlled trial of a financial navigation intervention to address cancer-related financial hardship.癌症财务体验（CAFÉ）研究：一项针对癌症相关经济困难的财务导航干预措施的随机对照试验。
Trials. 2022 May 13;23(1):402. doi: 10.1186/s13063-022-06344-3.
8
Understanding out-of-pocket spending and financial hardship among patients who succumb to cancer and their caregivers.了解癌症患者及其照顾者的自付支出和经济困难。
Isr J Health Policy Res. 2022 Jan 3;11(1):1. doi: 10.1186/s13584-021-00511-8.
9
Assessing the Accuracy of Sales Forecasts Submitted by Pharmaceutical Companies Applying for Reimbursement in Austria.评估申请奥地利报销的制药公司提交的销售预测的准确性。
Front Pharmacol. 2021 Aug 13;12:726758. doi: 10.3389/fphar.2021.726758. eCollection 2021.
10
Impact of Cost Conversation on Decision-Making Outcomes.成本沟通对决策结果的影响。
Mayo Clin Proc Innov Qual Outcomes. 2021 Jun 12;5(4):802-810. doi: 10.1016/j.mayocpiqo.2021.05.006. eCollection 2021 Aug.